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However, clinicians and investigators have long hypothesized that reducing metabolic demand could buy time for patients suffering from insufficient blood supply until they can receive definitive treatment. 3 Theoretically, decreased metabolic demand increases tolerance of cells and tissues to hypoxia and shortages of other essential physiologic parameters that result from injuries such as hemorrhage. Hypothermia is one technique used to reduce metabolic demand and improve outcome. 4 Although hypothermia is not used clinically as a treatment for hemorrhage in humans, it does improve outcome in animal models of blood loss. 5 However, hypothermia is itself a physiologic stress and presents many liabilities that temper its use. 6 Additional techniques that reduce metabolic demand are needed to better understand and practice this potentially useful type of treatment.
Recently, we showed that metabolic demand could be reduced in mice by exposing them to 80 ppm hydrogen sulfide, (H 2 S). 7 Subsequently, we hypothesized and showed that pretreatment of mice with H 2 S protects them from lethal hypoxia. 8 Although H 2 S is a potent toxin, many people experience brief high-dose exposures of 1,000 ppm or more and make spontaneous recoveries. 9 Together these data provide evidence that H 2 S can elicit a profound yet reversible effect on metabolism and homeostasis. The above facts led us to hypothesize that H 2 S could be used as a treatment for injuries and diseases that result in decreased supply of metabolic substrates such as oxygen. To test this hypothesis, we conducted the following study to analyze whether inhaled gaseous H 2 S or intravenous (IV) administered sulfide solution would improve survival in a rat model of lethal hemorrhage.
MATERIALS AND METHODS
This study was approved by the Institutional Animal Care and Use Committees of the Fred Hutchinson Cancer Research Center and the Department of Defense. All procedures followed national guidelines for the care and use of laboratory animals.
Male Sprague-Dawley rats 250 to 350 g were purchased from Charles River Laboratories, Hollister, CA. Rats were allowed free access to food and water, were housed two per cage, and used randomly for experiments.
For hemorrhage experiments, right femoral artery and vein were cannulated with PE50 tubing during sterile cutdown. Before surgery, rats were anesthetized using 2.5% isoflurane in 100% oxygen supplied at 1 L/min (Fig. 1, Ϫ160 minutes). Catheters were tunneled to and exited from the scapular region. Animals were kept warm with a heating pad. After surgery, animals were allowed to recover in a cage while being warmed with a heat lamp (Fig. 1, Ϫ100 to Ϫ40 minutes). At the beginning of the postsurgical recovery period, 0.05 mg/kg buprenorphine was administered subcutaneously and 30 units of Heparin was administered IV (Fig. 1 , Ϫ100 minutes). After animals were conscious and mobile (approximately 1 hour after end of surgery), they were transferred to a 2.75 L glass bowl (Fig. 1, Ϫ40 minutes) . The bowl was fitted with a glass lid and room air was supplied at 3 L/min. Flows of all gases were regulated using Sierra Instruments thermal mass flow controllers. Ambient temperature was maintained at 28 Ϯ 2°C using a temperature controlled water mat placed under the glass bowl. Catheters were passed through a hole in the lid. Blood was removed at constant rate using a peristaltic pump and measured using Mettler balance. H 2 S gas was purchased from Byrne Gas (Seattle, WA). Sulfide solution was obtained from Ikaria Inc (Seattle, WA).
Blood was removed from the arterial catheter. Total blood volume was calculated as 6.6% of body mass plus 0.77. 10 Sixty percent of total blood was removed in 40 minutes (Fig. 1, Ϫ40 to 0 minutes).
In group 1, test rats were given H 2 S gas diluted to 300 ppm in room air 20 minutes after initiation of blood removal, (Fig. 1 , group 1, Ϫ20 to 0 minutes). H 2 S was supplied for 20 minutes, until the end of the bleed (Fig. 1 , group 1, Ϫ20 to 0 minutes). At the end of the hemorrhage period (Fig. 1, 0 minutes) , H 2 S was removed from the air supply and animals continued to breath room air. Control rats in this first group were given a volume of nitrogen equal to the volume of H 2 S used above, diluted into room air. Surviving rats either received 1 shed-blood volume of lactated ringers solution administered IV 3 hours after the end of the bleed or lactated ringers to drink at 3 hours with no IV fluids ( Fig. 1, 180 minutes) . We found that the method of resuscitation did not impact the outcome of our experiments as only one animal died after the 3-hour period following the end of the bleed.
In group 2, test rats were administered a single IV dose (1 mg/kg) of sulfide solution (approximately 100 to 150 mL) 20 minutes after initiation of blood removal (Fig. 1 , group 2, Ϫ20 minutes). Control rats in this second group received an equal volume of vehicle solution (NaCl, 270 -300 mOsm, pH 5-6). Surviving animals received lactated ringers to drink 3 hours after the end of the bleed (Fig. 1, 180 minutes) ; they did not receive IV fluids.
Blood chemistry analysis was performed using an I-stat blood analyzer. Statistical analyses were performed according to recommendations of Fred Hutchinson Cancer Research Center clinical statistician Katherine A. Guthrie. Log-rank analysis was performed using SAS software to compare survival of treated and untreated rats. Two-sample t tests were performed using Microsoft Excel to compare differences between pre-and posthemorrhage arterial blood values between treated and untreated rats.
Exhaled carbon dioxide (CO 2 ) was measured using a Licor 7000 carbon dioxide analyzer. VCO 2 was calculated using flow rate of supplied air and body mass of rat.
RESULTS
In preparation for hemorrhage studies, we assayed the effects of H 2 S on metabolism in rats by measuring exhaled carbon dioxide (VO 2 ), a surrogate measure of metabolism. Figure 2 shows the VCO 2 of a representative rat in 300 ppm H 2 S. When H 2 S administration begins, VCO 2 decreases more than 3-fold in the first 5 minutes. After 10 minutes, VCO 2 stabilizes at about half the value before H 2 S administration. When H 2 S is removed after 20 minutes, VCO 2 returns to the preadministration value. In addition, we analyzed that 1 mg/kg sulfide solution delivered IV can induce temporary and reversible apnea and unconsciousness in rats (data not shown). These doses are well tolerated by rats and induce no detectable obvious long-term behavioral or functional defects.
Because both inhaled H 2 S gas and IV administered liquid sulfide are active, we tested both in a rat model of hemorrhage. In group 1, rats administered 300 ppm H 2 S, 75% (18 of 24) of the treated animals survived past the end of the monitoring period which was 2 weeks after the hemorrhage. The average survival time of the other six treated rats was 113 Ϯ 71 minutes. In the control group, 23% (3 of 13) of the rats survived past the end of monitoring period. The average survival time of the other 10 untreated rats was 64 Ϯ 23 minutes after the end of the bleed. 
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In group 2, rats administered 1 mg/kg IV sulfide solution, 66% (8 of 12) of the treated animals survived past the end of the monitoring period. The average survival time of the four additional treated rats was 144 Ϯ 75 minutes. Control rats in this second group received an equal volume of vehicle solution. Fourteen percent (1 of 7) of the animals survived past the end of the monitoring period. The other six control rats survived 31 Ϯ 14 minutes. These survival data are shown in the Kaplan Meier curve in Figure 3 . Using log-rank analysis, p Ͻ 0.001.
Blood chemistry analysis was performed using arterial samples collected just before and just after blood removal.
Treated and untreated rats displayed the same posthemorrhage changes in blood chemistry: lower PCO 2 , HCO 3 and base excess and higher lactate and potassium (Tables 1 and  2) . However, in H 2 S gas treated animals, the magnitudes of the differences in PCO 2 , HCO 3 , base excess, lactate, and potassium were significantly smaller than those in control animals ( Table 2 ; Inhaled H 2 S gas).
Functional and behavior tests performed on long-term survivors (animals that lived greater than 2 weeks after hemorrhage) showed no observable defects. Additionally, two long-term survivors were mated and each produced normal sized litters of normal pups. To learn more about the metabolic effects of H 2 S during hemorrhage, we measured VCO 2 in a subset of H 2 S gas treated rats. Figure 4 , A shows the VCO 2 from seven treated and seven control rats. It is apparent that VCO 2 begins to drop immediately after blood removal begins. Approximately, half way through the bleed, at about the same time the H 2 S administration begins, the VCO 2 stabilizes in treated rats and remains constant until resuscitation. In control rats, VCO 2 continues to fall until it ceases altogether. Figure 4 , B shows all 14 VCO 2 traces form treated and control rats during hemorrhage. There are no observable differences between treated and control rats before H 2 S administration.
DISCUSSION
These data demonstrate that H 2 S can lower metabolic output in rats and that H 2 S treatment improves survival in a rat model of lethal hemorrhage. However, the initial hypothesis that H 2 S lowers metabolic demand during hemorrhage is difficult to prove. H 2 S administration during hemorrhage does not reduce metabolic output as it does in a nonhemor- The Journal of TRAUMA Injury, Infection, and Critical Care rhaged rat. In fact, it correlates with sustained metabolic output in a hemorrhaged rat (without H 2 S treatment, metabolic output of rats decreases to zero). It is important to note that metabolic output, as measured by VO 2 and core body temperature, decreases during hemorrhage. 11 As such, H 2 S administration could reduce metabolic demand without reducing apparent metabolic output once that output has been reduced by hemorrhage. This idea is consistent with the observation that VCO 2 does not increase after H 2 S administration ends (as it does in uninjured rats). This potential H 2 S dependent reduction of metabolic demand could promote a more sustainable physiologic balance between energy supply and energy demand and more efficient usage of the reduced metabolic substrates such as oxygen that result from hemorrhage. This is consistent with the observation that VCO 2 stabilizes after H 2 S treatment and does not continue to decrease as it does in untreated rats. Additional experiments, including analysis of oxygen delivery, consumption, and demand in animals treated with H 2 S, are warranted to further characterize the effects of H 2 S on metabolism.
There are a number of specific mechanisms that could account for or contribute to the beneficial effects of both inhaled H 2 S gas and IV administered sulfide solution. Exogenous sulfide might compensate for the inability of endogenous systems to maintain redox or sulfide balance. During and after hemorrhage, sulfhydryl levels decrease 12 and reactive oxygen species increase. 13 Endogenous sulfide homeostasis is maintained by a number of mechanisms. H 2 S can be produced by the enzymes cystathionine synthase, cystathionine lyase, and mercaptopyruvate sulfurtransferase. 14 H 2 S is also produced by cysteine desulfurase enzymes that can produce sulfide for metal-sulfur prosthetic groups. 15, 16 In addition, human erythrocytes and liver can produce H 2 S by reducing elemental sulfur. 17, 18 During lethal hemorrhage, these mechanisms may fail to meet demand; treatment using gaseous H 2 S or sulfide solution might supplement this shortage.
Alternatively, sulfide-induced reduction in oxygen demand could enable cells and tissues to better withstand local and temporary low oxygen that results from hemorrhage. This mechanism is supported by the fact that many proteins can be profoundly affected by sulfide. Sulfide is electronegative and exhibits high affinity for transition metals. Proteins containing transition metal atoms, such as cytochrome c oxidase, can be inhibited by H 2 S. 9 Furthermore, many proteins contain disulfide linked cysteine residues, and the sulfide mediated reversible conversion from free thiol to disulfide can regulate specific enzyme activities. 19 Together, the coupled effects of H 2 S on cytochrome c oxidase and the potential widespread effects on downstream energy consuming processes could reduce oxygen demand.
Finally, sulfide might affect neuroendocrine pathways in ways that protect animals from lethal hemorrhage. It is well known that neural and endocrine systems play important roles in the physiologic response to hemorrhage. 20 Recently, it was shown that vagal stimulation reduces hemorrhage-induced inflammation. 21 Because the vagus nerve is also required for H 2 S mediated physiology, 22, 23 it is possible that H 2 S stimulation of the vagus nerve or other neuroendocrine pathways contribute to the benefit we observe. This phenomenon could simultaneously impact multiple aspects of homeostasis including inflammation, metabolism, and cardiopulmonary and vascular function.
That 300 g rats require more H 2 S (300 ppm) than 25 g mice (80 ppm) suggests body mass or associated differences in metabolic rate affect the physiological response to sulfide. Future experiments in large animals or use in humans will likely require higher doses of H 2 S. Therefore, a rigorous reexamination of the toxic effects of H 2 S will be required.
An important aspect of the development of hydrogen sulfide as a drug for use in this indication will require a detailed review of the toxicity. Past work suggests that a target organ for hydrogen sulfide toxicity is the airway including lung and nasal epithelium; however, these studies were designed to test for hazards in the workplace and as a result were long-term exposure studies and not performed on compromised animals. For this reason, formal toxicology studies will be required as a part of the development path. If validated, this treatment could be easily administered as a field injectable or inhalable dose of sulfide that could be given to an individual as soon after an injury as possible to buy time until definitive care is available.
